Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer
2018 · British Journal of Cancer · 81 citations
https://doi.org/10.1038/s41416-018-0150-6
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
254
Citations
7
h-index
7
i10-index
Justus Körfer is an academic researcher from Dbe Technology (Germany). The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Cancer Immunotherapy and Biomarkers & Cancer Cells and Metastasis. The author has an h-index of 7, co-authored 12 publications.
Click to start Chat